Elbasvir/grazoprevir administered for 12 weeks via Percutaneous Endoscopic Gastrostomy Tube Achieves Sustained Virologic Response: A Case Report and a Review of the Literature
2019 ◽
Vol 114
(1)
◽
pp. S799-S800
2020 ◽
Vol 68
◽
pp. 166-169
2004 ◽
Vol 49
(11-12)
◽
pp. 1815-1817
◽
2005 ◽
Vol 84
(3)
◽
pp. 222
◽
2017 ◽
Vol 112
◽
pp. S981-S982